Login
Subscribe
Frontiers Removes Controversial Ivermectin Paper Pre-Publication
Frontiers Removes Controversial Ivermectin Paper Pre-Publication
A review article containing contested claims about the tropical medicine drug as a COVID-19 treatment was listed as “provisionally accepted” on the journal’s website before being removed this week.
A review article containing contested claims about the tropical medicine drug as a COVID-19 treatment was listed as “provisionally accepted” on the journal’s website before being removed this week.
peer review, disease & medicine
How (Not) to Do an Antibody Survey for SARS-CoV-2
Catherine Offord | Apr 28, 2020 | 10+ min read
Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.